Alimera Sciences Inc (ALIM.O)

ALIM.O on Consolidated Issue listed on NASDAQ Global Market

5.91USD
27 Aug 2014
Price Change (% chg)

$0.26 (+4.60%)
Prev Close
$5.65
Open
$5.71
Day's High
$5.92
Day's Low
$5.70
Volume
111,609
Avg. Vol
156,729
52-wk High
$8.44
52-wk Low
$1.65

ALIM.O

Chart for ALIM.O

About

Alimera Sciences, Inc.is a biopharmaceutical company that develops and commercializes prescription ophthalmic pharmaceuticals. The Company advanced product candidate, ILUVIEN, is a tiny, cylindrical polyimide tube that contains 190 g of fluocinolone acetonide (FAc), a corticosteroid with a history of treating ocular diseases.... (more)

Overall

Beta: 1.29
Market Cap (Mil.): $228.40
Shares Outstanding (Mil.): 40.42
Dividend: --
Yield (%): --

Financials

  ALIM.O Industry Sector
P/E (TTM): -- 32.67 33.58
EPS (TTM): -1.05 -- --
ROI: -94.63 18.00 17.30
ROE: -- 18.64 18.05
Search Stocks

Alimera makes fourth bid for eye treatment approval from FDA

- Alimera Sciences Inc said it has applied a fourth time for U.S. regulatory approval to start selling an eye implant that delivers a drug to treat a form of blindess in diabetes patients.

27 Mar 2014

Alimera makes fourth bid for eye treatment approval from FDA

March 27 - Alimera Sciences Inc said it has applied a fourth time for U.S. regulatory approval to start selling an eye implant that delivers a drug to treat a form of blindess in diabetes patients.

27 Mar 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks